{"disease":{"id":"neuroectodermal-tumors-primitive","name":"neuroectodermal tumors primitive"},"drugs":{"marketed":[],"pipeline":[],"offLabel":[],"totalMarketed":0,"totalPipeline":0},"trials":{"data":[{"nct_id":"NCT00923351","title":"Therapy to Treat Ewing's Sarcoma, Rhabdomyosarcoma or Neuroblastoma","phase":"PHASE1, PHASE2","overall_status":"COMPLETED","enrollment_count":44,"lead_sponsor_name":"National Cancer Institute (NCI)","has_results":true},{"nct_id":"NCT03911388","title":"HSV G207 in Children With Recurrent or Refractory Cerebellar Brain Tumors","phase":"PHASE1","overall_status":"RECRUITING","enrollment_count":24,"lead_sponsor_name":"M.D. Anderson Cancer Center","has_results":false},{"nct_id":"NCT01661400","title":"Anti-Angiogenic Therapy Post Transplant (ASCR) for Pediatric Solid Tumors","phase":"PHASE1","overall_status":"COMPLETED","enrollment_count":14,"lead_sponsor_name":"Washington University School of Medicine","has_results":false}],"total":3},"guidelines":[],"source":"Drug Landscape verified database"}